current affair

In April 2021, Bharat Biotech said that COVAXIN has shown the efficacy of 78% against mild, moderate, and severe COVID-19 infections, as per the Phase 3 interim analysis results.

from Jagran Josh https://ift.tt/3gLMjly
via IFTTT